siRNA for cervical cancer (ImuThes Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamesiRNA for cervical cancer (ImuThes Therapeutics)
Drug Alias Namesmall interfering RNA for cervical cancer (ImuThes Therapeutics)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImuThes Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImuThes Ltd
Active IndicationsN/A
Inactive IndicationsUterine Cervical Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A